Article Details

Antibody escape and global spread of SARS-CoV-2 lineage A.27 | Nature Communications

Retrieved on: 2022-03-03 10:14:23

Tags for this article:

Click the tags to see associated articles and topics

Antibody escape and global spread of SARS-CoV-2 lineage A.27 | Nature Communications. View article details on hiswai:

Excerpt

Thus, multiple RBD-specific monoclonal antibodies (mAb) are assessed in clinical trials or are approved to treat COVID-19, including Bamlanivimab (LY- ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up